Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation
Deep TMS for Alcoholism
N/A
Waitlist Available
Led By Timothy Durazzo, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will study whether a treatment called deep transcranial magnetic stimulation (dTMS) is effective for Veterans with AUD.
Who is the study for?
This trial is for Veterans aged 21-70 with alcohol use disorder (AUD) who are in active treatment, can consent in English, and have been sober for at least 7 days. It's not for those with severe heart or lung conditions, metal implants incompatible with magnetic fields, certain psychiatric disorders like schizophrenia or bipolar disorder, pregnant women, or anyone on medications that lower seizure threshold.
What is being tested?
The study tests deep transcranial magnetic stimulation (dTMS) using an H7 coil to treat AUD in Veterans. Participants will receive dTMS while continuing any current depression treatments as long as they don't increase the risk of seizures.
What are the potential side effects?
While dTMS is generally safe and well-tolerated, potential side effects may include headache, scalp discomfort at the site of stimulation, lightheadedness, and a rare risk of seizure. Other less common side effects might occur.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Participants With Relapse to Alcohol 6 Months After Treatment
Percentage of Days Abstinent
Percentage of Days of Heavy Drinking
Secondary study objectives
Change from Baseline in Emotion regulation skills
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Active dTMSExperimental Treatment1 Intervention
Participants will receive 30 dTMS treatments, administered 3 times per day over 10 consecutive business days, Each treatment visit will last approximately 30 minutes in total.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,491 Previous Clinical Trials
17,519,204 Total Patients Enrolled
16 Trials studying Alcoholism
3,282 Patients Enrolled for Alcoholism
VA Palo Alto Health Care SystemFED
93 Previous Clinical Trials
57,994 Total Patients Enrolled
2 Trials studying Alcoholism
49 Patients Enrolled for Alcoholism
Timothy Durazzo, PhDPrincipal InvestigatorStanford University
Claudia Padula, PhDPrincipal InvestigatorStanford University
Michelle Madore, PhDPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your thyroid disease is not well managed or under control.You have chronic lung disease (COPD) and need to use supplemental oxygen.You have been diagnosed with schizophrenia or bipolar disorder.It seems like you've provided a very broad criterion without specific details. Could you please provide more context or clarify what specific biomedical criterion you would like me to summarize?You have a condition called angina, which causes chest pain or discomfort.Your diabetes is not under control and is causing frequent changes in your blood sugar levels.You have Alzheimer's disease.You have Parkinson's disease.You have a mental health condition that may affect your ability to participate in the study.You currently have a serious problem with using drugs (except alcohol, tobacco, or marijuana) according to the standards set by doctors.I'm sorry, but I need more specific information about the general criterion in order to provide a simplified explanation. Please provide additional details or specify which general criterion you are referring to.This includes, but is not limited to:You have a heart condition that is not well-controlled or stable.You have had a stroke or have had cancer and it has been less than one year since you finished treatment.You have had a severe head injury with loss of consciousness for more than 30 minutes, a seizure disorder caused by injury, or seizures from alcohol within the past month.
Research Study Groups:
This trial has the following groups:- Group 1: Active dTMS
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.